Back to funds

ADAR1 Capital Management, LLC

Updated 6 days ago

Managed by Adar1 Capital Management, Llc • Latest filing Q3 2026

Portfolio value
$2.2B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
99.2%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.4B
Q1 2026$1.7B
Q2 2026$2.2B
Q3 2026$2.2B

Top holdings

6 positions as of Q3 2026

View filing
A

ABIVAX SA

Value
$203.1M
Shares
2.05M
% Port
9.25%
S

STATE STR SPDR S&P 500 ETF T

Value
$135.5M
Shares
177.6K
% Port
6.17%
P

PROTAGONIST THERAPEUTICS INC

Value
$134M
Shares
951.4K
% Port
6.11%
R

ROIVANT SCIENCES LTD

Value
$112.6M
Shares
3.08M
% Port
5.13%
I

IMMUNOVANT INC

Value
$71.5M
Shares
2.12M
% Port
3.26%
D

DENALI THERAPEUTICS INC

Value
$42.8M
Shares
2.07M
% Port
1.95%
?
7.N/A

EA SERIES TRUST

Value
$39.9M
Shares
337.1K
% Port
1.82%
S

SEPTERNA INC

Value
$38.1M
Shares
974.4K
% Port
1.74%
M

AGIOS PHARMACEUTICALS INC

Value
$37.9M
Shares
1.14M
% Port
1.73%
A

AURA BIOSCIENCES INC

Value
$33.8M
Shares
5.39M
% Port
1.54%
V

VIKING THERAPEUTICS INC

Value
$33.7M
Shares
1.03M
% Port
1.54%
C

CYTOKINETICS INC

Value
$30.4M
Shares
461.4K
% Port
1.39%
I

INSMED INC

Value
$26.2M
Shares
229.5K
% Port
1.19%
F

FREENOME INC

Value
$25.9M
Shares
1.65M
% Port
1.18%
C

CELLDEX THERAPEUTICS INC NEW

Value
$25.9M
Shares
799.3K
% Port
1.18%
A

ANTERIS TECHNOLOGIES GLOBAL

Value
$25.2M
Shares
3.24M
% Port
1.15%
B

BRIDGEBIO PHARMA INC

Value
$25M
Shares
379.3K
% Port
1.14%
P

PRAXIS PRECISION MEDICINES I

Value
$24.7M
Shares
84.8K
% Port
1.12%
?
19.N/A

FULCRUM THERAPEUTICS INC

Value
$24.6M
Shares
6.65M
% Port
1.12%
V

VIR BIOTECHNOLOGY INC

Value
$24.1M
Shares
2.16M
% Port
1.10%

Explore